Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
TLL
₹262.50
₹262.00
₹275.00
Data is not available
Markets Today
Historical Performance
As of 10-07-2026 22:19, Trident Lifeline Ltd. share price today is ₹0, with a change of ₹-264.10 (-100.00%) from the previous close of ₹264.1. The stock opened at ₹265 and traded between ₹262 and ₹275, with a total traded volume of 42000 shares. The company has a market capitalization of ₹307.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹328 and ₹229.95, respectively.
Trident Lifeline Ltd. valuation metrics include a P/E ratio of 16.2, EPS of ₹16.32, and book value of ₹3.20. Profitability indicators show ROE of 18.96%. Trident Lifeline Ltd. has reported revenue of ₹129.02 Cr and net profit of ₹19.04 Cr.
Trident Lifeline Ltd. technical indicators include Day RSI at 57.78, Day MFI at 69.82, Day ADX at 25.5. Additional indicators include Commodity Channel Index (CCI) at 90.6 and Williams %R at -43.15. Momentum indicators show Day MACD at 3.64, Day MACD Signal Line at 2.74, DayATR at 8.98. Rate of Change indicators for Trident Lifeline Ltd. include ROC125 at -11.38 and ROC21 at 7.07.
Exponential moving averages include EMA5 at ₹262.2, EMA10 at ₹260.4, EMA12 at ₹259.7, EMA20 at ₹257.2, EMA26 at ₹256, EMA50 at ₹255, EMA100 at ₹259.7, EMA200 at ₹266.6. Simple moving averages include SMA5 at ₹262.7, SMA10 at ₹262.5, SMA20 at ₹255, SMA30 at ₹252, SMA50 at ₹253.3, SMA100 at ₹255, SMA150 at ₹270.5, SMA200 at ₹276.8.
Support levels for Trident Lifeline are placed at First Support ₹259.67, Second Support ₹255.23, Third Support ₹249.57. Resistance levels are seen at First Resistance ₹269.77, Second Resistance ₹275.43, Third Resistance ₹279.87. Trident Lifeline Ltd. shareholding pattern shows promoter holding at 62.85%, FII holding at 7.24%, DII holding at 0%, public holding at 29.64%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 31.97 | 23.67 | 27.44 | 18.82 | 20.89 |
| Operating Expense | 25.23 | 17.39 | 21.06 | 13.89 | 16.01 |
| Operating Profit | 6.74 | 6.28 | 6.38 | 4.93 | 4.88 |
| Depreciation | 0.04 | 0.71 | 0.59 | 0.51 | 0.67 |
| Interest | 0.38 | 0.54 | 0.42 | 0.33 | 0.41 |
| Tax | 2.29 | 1.91 | 1.54 | 1.15 | 1.80 |
| Net Profit | 5.66 | 4.01 | 4.94 | 3.48 | 3.62 |
₹262.50
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 63 | 63 | 63 | 63.1 | 64.1 | 62.8 |
| FII | 6.1 | 6.6 | 7.2 | 7.7 | 7 | 7.2 |
| DII | 0 | 0.1 | 0.4 | 0.4 | 0.4 | 0.3 |
| Public | 30.9 | 30.2 | 29.4 | 28.8 | 28.5 | 29.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 27.6 K | 39 K | 70.77% |
| Week | 25.56 K | 36.84 K | 69.38% |
| 1 Month | 24.57 K | 36.86 K | 66.67% |
| 6 Month | 22.03 K | 30.66 K | 71.85% |
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Undervalued Growth Stocks
Jim Slater's Zulu Principle (Discover Growth Stocks)
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with reducing Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
RSI indicating price strength
Top Gainers
Insiders bought stocks
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹41 | ₹587.60 | ₹183.50 | ₹259.30 | ₹35 | ₹5.40 |
| % Change | 0.00% | -1.43% | -0.27% | 0.00% | -2.78% | -0.18% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹1.27 | ₹83.60 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.25 | ₹-34.95 |
| PE TTM | 9.60 | - | 12.40 | 37.00 | -85.20 | -1.30 |
| 1 Year Return | 52.07 | 700 | 441 | |||
| ROCE | - | 3.56 | - | - | - | -5.63 |
Aptus Pharma Ltd.
₹ 224.00
+1.93%
Amanta Healthcare Ltd.
₹ 179.17
-2.00%
Anlon Healthcare Ltd.
₹ 15.60
+0.84%
Patel Chem Specialities Ltd.
₹ 95.00
-1.04%
Asston Pharmaceuticals Ltd.
₹ 76.50
+1.32%
Amrutanjan Health Care Ltd.
₹ 535.00
-0.10%
Astonea Labs Ltd.
₹ 282.55
+1.99%
Amwill Health Care Ltd.
₹ 41.00
-3.91%
Valiant Laboratories Ltd.
₹ 62.00
-0.26%
Shelter Pharma Ltd.
₹ 27.40
+6.41%
Dipna Pharmachem Ltd.
₹ 5.76
-8.86%
Achyut Healthcare Ltd.
₹ 8.20
+0.12%
Sigachi Industries Ltd.
₹ 22.67
+1.98%
Windlas Biotech Ltd.
₹ 830.00
+0.50%
Vineet Laboratories Ltd.
₹ 32.80
+0.43%
Chandra Bhagat Pharma Ltd.
₹ 38.55
-4.98%
Cian Healthcare Ltd.
₹ 8.67
+0.00%
Solara Active Pharma Sciences Ltd.
₹ 568.90
+0.36%
Rajnish Wellness Ltd.
₹ 0.41
+0.00%
Zim Laboratories Ltd.
₹ 113.62
-1.99%
Bharat Parenterals Ltd.
₹ 1402.00
-0.61%
Medico Remedies Ltd.
₹ 39.10
+0.03%
Shree Ganesh Remedies Ltd.
₹ 687.00
+1.43%
By signing up I certify terms, conditions & privacy policy